
Tuberculosis Infection in a Patient with Lung Cancer under PD-L1 Inhibition: A Case Report
Author(s) -
Eleni Papadaki,
Κaterina Manika,
Boutis Anastasios,
Ioannis Kioumis,
Theodoros Kontakiotis
Publication year - 2020
Publication title -
journal of tuberculosis research
Language(s) - English
Resource type - Journals
eISSN - 2329-8448
pISSN - 2329-843X
DOI - 10.4236/jtr.2020.83014
Subject(s) - medicine , tuberculosis , adverse effect , immunotherapy , durvalumab , lung cancer , nivolumab , cancer , immunology , immune system , immunity , oncology , intensive care medicine , pathology